News

The confluence of recent economic factors and emerging clinical evidence now makes the use of central venous access devices (CVADs) far less desirable than in the past. Conversely, the same factors and facts greatly enhance the appeal of midline catheterscatheters measuring 3 to 8 inches in length, inserted in an upper arm vein and with tip location distal to the shoulder.(1,2) Evidence now demonstrates that certain Midlines offer patients the possibility of full length of stay infusion therapy, with reduced risk of bloodstream infection and avoidance of repetitive needlesticks for labs and restarts. Thus, in many cases, midlines are becoming the go-to device for safe, uninterrupted intravenous (IV) therapy.

Some types of ear infections may one day be as rare as polio and smallpox thanks to a vaccine thats being developed by a team of researchers at Nationwide Childrens Hospital. The vaccine which targets the bacteria responsible for nearly one half of all ear infections wont be delivered by a needle jab, but absorbed through the skin via a small, dime-sized patch.

Immune system B cells play a crucial role in the defence of pathogens; when they detect such an intruder, they produce antibodies that help to combat the enemy. They concurrently and continuously improve these molecules to more precisely recognize the pathogens. A team of scientists with participation of the Helmholtz Centre for Infection Research (HZI) has discovered that during this process the cells are able to advance their own evolution themselves by increasing the selection pressure through previously-produced antibodies. The results are also significant for the development of new vaccination strategies.

In recent years, a body of pub­li­ca­tions in the micro­bi­ology field has chal­lenged all pre­vious knowl­edge of how antibi­otics kill bac­teria. A slew of papers came out studying this phe­nom­enon, sug­gesting that there is a gen­eral mech­a­nism of killing by antibi­otics, says Kim Lewis, Uni­ver­sity Dis­tin­guished Pro­fessor in the Depart­ment of Biology and director of Northeasterns Antimi­cro­bial Dis­covery Center.

Activities to stop the spread of the intestinal superbug Clostridium difficile are on the rise, but they are not yielding large improvements, according to a nationwide survey of infection preventionists released today by the Association for Professionals in Infection Control and Epidemiology (APIC).